We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
+$34.5M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.95%
Holding
1,364
New
25
Increased
674
Reduced
255
Closed
34

Sector Composition

Rank Sector Weight
1 Real Estate 53.25%
2 Technology 12.67%
3 Healthcare 4.74%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1126
Recursion Pharmaceuticals
RXRX
$1.61B
$6K ﹤0.01%
731
SUPN icon
1127
Supernus Pharmaceuticals
SUPN
$2.78B
$6K ﹤0.01%
217
SWTX
1128
DELISTED
SpringWorks Therapeutics
SWTX
$6K ﹤0.01%
251
VCYT icon
1129
Veracyte
VCYT
$4.55B
$6K ﹤0.01%
266
ABCL icon
1130
AbCellera Biologics
ABCL
$1.63B
$5K ﹤0.01%
1,151
AGIO icon
1131
Agios Pharmaceuticals
AGIO
$2.12B
$5K ﹤0.01%
204
AMLX icon
1132
Amylyx Pharmaceuticals
AMLX
$2.17B
$5K ﹤0.01%
266
BCRX icon
1133
BioCryst Pharmaceuticals
BCRX
$2.47B
$5K ﹤0.01%
692
CVAC
1134
DELISTED
CureVac
CVAC
$5K ﹤0.01%
697
DBC icon
1135
Invesco DB Commodity Index Tracking Fund
DBC
$1.68B
$5K ﹤0.01%
200
IDYA icon
1136
IDEAYA Biosciences
IDYA
$3.5B
$5K ﹤0.01%
193
IMCR icon
1137
Immunocore
IMCR
$1.72B
$5K ﹤0.01%
104
MIRM icon
1138
Mirum Pharmaceuticals
MIRM
$6.74B
$5K ﹤0.01%
148
MRVI icon
1139
Maravai LifeSciences
MRVI
$1.02B
$5K ﹤0.01%
490
MYGN icon
1140
Myriad Genetics
MYGN
$504M
$5K ﹤0.01%
326
PCRX icon
1141
Pacira BioSciences
PCRX
$1.06B
$5K ﹤0.01%
169
RYTM icon
1142
Rhythm Pharmaceuticals
RYTM
$7.4B
$5K ﹤0.01%
227
SAGE
1143
DELISTED
Sage Therapeutics
SAGE
$5K ﹤0.01%
239
SMMT icon
1144
Summit Therapeutics
SMMT
$10.1B
$5K ﹤0.01%
2,728
VIR icon
1145
Vir Biotechnology
VIR
$1.5B
$5K ﹤0.01%
535
ZLAB icon
1146
Zai Lab
ZLAB
$2.05B
$5K ﹤0.01%
193
-85
-31% -$2.26K
CBAY
1147
DELISTED
Cymabay Therapeutics
CBAY
$5K ﹤0.01%
341
ANIP icon
1148
ANI Pharmaceuticals
ANIP
$1.82B
$4K ﹤0.01%
70
ARVN icon
1149
Arvinas
ARVN
$529M
$4K ﹤0.01%
198
AUPH icon
1150
Aurinia Pharmaceuticals
AUPH
$1.94B
$4K ﹤0.01%
528

Similar funds

Daiwa Securities Group's Q3 2023 Portfolio in Review

As of Q3 2023, Daiwa Securities Group held 1,364 positions worth $14B, down 7.2% from $15.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.3%. Daiwa Securities Group opened 25 new positions and exited 34, leaving the 1,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2023 buy was Kenvue: 139,472 shares worth $2.8M.
  • Daiwa Securities Group added most to American Tower in Q3 2023, an estimated $233M increase.
  • Daiwa Securities Group's biggest Q3 2023 reduction was Digital Realty Trust, cutting an estimated $154M.
  • Daiwa Securities Group fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $5.38M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $14B portfolio in Q3 2023.
  • Daiwa Securities Group opened 25 new positions and closed 34 in Q3 2023.
  • Daiwa Securities Group's portfolio value fell 7.2% quarter-over-quarter to $14B.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.